中华顶尖财经--信息搜索

信息搜索

信息关键字：医药

共有1868条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]

·“拿下”国产新冠口服药！刚刚，300亿医药股强势涨停！新冠药概念集体爆发，最强者已11天9涨停！2022-5-9 21:04:53

·医药行业中药板块2021年报及22Q1季报总结：板块走向分化一季度疫情扰动较大2022-5-9 21:02:39

·医药行业疫苗板块2021年报及2022一季报总结：新冠疫苗叠加重磅品种放量助力板块延续高增长2022-5-9 20:56:53

·医药生物行业周报：和黄医药、君实生物相继被FDA拒绝创新药出海需全面了解当地监管规则2022-5-9 18:06:10

·复盘167涨停股：中国医药炸板华润双鹤封一字湖南发展9天8板2022-5-9 18:02:51

·复盘167涨停股：中国医药3板华润双鹤封一字湖南发展9天8板2022-5-9 16:05:42

·研报精选：肝素概念站上风口！千红制药、华润双鹤等狂飙医药股还能疯多久？2022-5-9 13:37:59

·医药生物行业投资策略：2021年报及2022一季报上市公司总结2022-5-9 11:52:07

·中国医药触及涨停2022-5-9 9:41:12

·A股药企期间费用放大镜：上海医药豪掷62亿广告费百济神州研发投入最多2022-5-8 18:21:56

·医药生物行业跟踪周报：消费医疗尤其CGM值得关注2022-5-8 14:14:50

·医药生物行业2021年及2022年一季报总结：至暗时刻乐观起来2022-5-8 9:35:52

·医药行业2022年5月投资月报：关注疫情后复苏三大主线2022-5-6 21:17:23

·复盘108涨停股：中国医药低位2板长安汽车、农发种业断板2022-5-6 16:09:47

·107只个股涨停主要集中在医药生物、计算机等行业2022-5-6 15:48:57

·融通医疗保健基金经理蒋秀蕾：医药估值性价比凸显2022-5-6 15:00:38

·研报精选：地产、白酒成砸盘先锋！医疗器械板块力挽狂澜精华制药、中国医药飙升2022-5-6 14:24:52

·新冠药概念股震荡走强中国医药涨停2022-5-6 9:52:45

·2021年A股研发费用逾12000亿元医药生物公司“最投入”2022-5-6 3:51:17

·毕得医药科创板首发申请获通过2022-5-5 20:47:15

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]